Arcadium Lithium Valuation
Is 7WO0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 7WO0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 7WO0 (€5.05) is trading below our estimate of fair value (€40.6)
Significantly Below Fair Value: 7WO0 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 7WO0?
Key metric: As 7WO0 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 7WO0's PE Ratio? | |
|---|---|
| PE Ratio | 36.7x |
| Earnings | US$155.10m |
| Market Cap | US$5.69b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 8x |
| Enterprise Value/EBITDA | 29.8x |
| PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does 7WO0's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 28.5x | ||
EVK Evonik Industries | 35.8x | 33.1% | €8.2b |
WCH Wacker Chemie | 28.3x | 37.0% | €3.5b |
SY1 Symrise | 37.8x | 13.2% | €14.8b |
ACT AlzChem Group | 12.1x | 12.6% | €606.5m |
7WO0 Arcadium Lithium | 36.7x | 29.8% | €5.7b |
Price-To-Earnings vs Peers: 7WO0 is expensive based on its Price-To-Earnings Ratio (36.7x) compared to the peer average (28.5x).
Price to Earnings Ratio vs Industry
How does 7WO0's PE Ratio compare vs other companies in the European Chemicals Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 7WO0 is expensive based on its Price-To-Earnings Ratio (36.7x) compared to the European Chemicals industry average (16.9x).
Price to Earnings Ratio vs Fair Ratio
What is 7WO0's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 36.7x |
| Fair PE Ratio | 33.8x |
Price-To-Earnings vs Fair Ratio: 7WO0 is expensive based on its Price-To-Earnings Ratio (36.7x) compared to the estimated Fair Price-To-Earnings Ratio (33.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €5.05 | €5.80 +14.8% | 16.5% | €8.64 | €4.14 | n/a | 19 |
| Nov ’25 | €4.97 | €5.43 +9.2% | 18.8% | €8.27 | €3.68 | n/a | 19 |
| Oct ’25 | €2.53 | €4.58 +81.1% | 42.2% | €8.98 | €2.60 | n/a | 21 |
| Sep ’25 | €2.43 | €4.72 +94.2% | 39.9% | €8.97 | €2.69 | n/a | 21 |
| Aug ’25 | €2.82 | €6.16 +118.3% | 39.7% | €12.93 | €3.46 | n/a | 20 |
| Jul ’25 | €3.11 | €6.92 +122.8% | 37.5% | €13.08 | €3.50 | n/a | 20 |
| Jun ’25 | €4.04 | €7.40 +83.1% | 31.6% | €12.96 | €4.63 | n/a | 18 |
| May ’25 | €4.04 | €7.57 +87.5% | 29.3% | €12.90 | €4.61 | n/a | 19 |
| Apr ’25 | €4.14 | €7.60 +83.6% | 29.9% | €12.86 | €4.59 | n/a | 19 |
| Mar ’25 | €5.11 | €8.08 +58.1% | 29.0% | €12.90 | €4.61 | n/a | 18 |
| Feb ’25 | €4.36 | €8.68 +99.2% | 25.6% | €12.91 | €5.53 | n/a | 18 |
| Jan ’25 | n/a | €9.50 0% | 28.3% | €14.22 | €5.61 | n/a | 18 |
| Dec ’24 | n/a | €9.57 0% | 28.8% | €14.39 | €5.68 | n/a | 18 |
| Nov ’24 | n/a | €11.14 0% | 24.9% | €17.70 | €7.28 | €4.97 | 18 |
| Oct ’24 | n/a | €12.52 0% | 15.4% | €17.24 | €9.58 | €2.53 | 18 |
| Sep ’24 | n/a | €12.52 0% | 15.4% | €17.24 | €9.58 | €2.43 | 18 |
| Aug ’24 | n/a | €12.42 0% | 15.8% | €16.91 | €9.39 | €2.82 | 18 |
| Jul ’24 | n/a | €12.52 0% | 16.0% | €17.15 | €9.53 | €3.11 | 18 |
| Jun ’24 | n/a | €12.69 0% | 16.6% | €17.50 | €9.72 | €4.04 | 17 |
| May ’24 | n/a | €12.30 0% | 17.6% | €17.07 | €8.73 | €4.04 | 16 |
| Apr ’24 | n/a | €12.86 0% | 17.7% | €17.68 | €9.04 | €4.14 | 16 |
| Mar ’24 | n/a | €12.75 0% | 17.7% | €17.68 | €9.04 | €5.11 | 17 |
| Feb ’24 | n/a | €12.61 0% | 16.6% | €17.21 | €8.42 | €4.36 | 17 |
| Jan ’24 | n/a | €13.22 0% | 14.3% | €17.64 | €10.59 | n/a | 16 |
| Dec ’23 | n/a | €13.73 0% | 14.2% | €18.06 | €10.83 | n/a | 16 |
| Nov ’23 | n/a | €13.95 0% | 16.0% | €18.55 | €11.13 | n/a | 16 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Ecora Resources
UK£162.5m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
HGR
UK£0.76
7D
1.5%
1Y
-28.3%
Stanmore Resources
AU$2.8b
Engages in the exploration, development, production, and sale of metallurgical coal in Australia.
S0D
AU$1.91
7D
4.9%
1Y
-15.5%
Tokuyama
JP¥196.7b
Produces and sells various chemical products in Japan.
TBT
JP¥16.60
7D
5.7%
1Y
14.5%